Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 743 All time
- Disclosed funding
- $25.4B 608 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| Q Builds fully autonomous robotic pharmacy for prescription fulfillment | $12.6M | Seed | Healthtech | United States | Investors | |
| XB Xellar BiosystemsCompany profile Develops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technology Develops 3D human tissue models for drug discovery and testing using Organ-on-a-Chip technology | $50M | Series A | Healthtech, Biotech | United States | Investors Undisclosed | |
| A AlanCompany profile Alan combines health insurance, preventive services and access to care in a digital platform for employers and members. Alan combines health insurance, preventive services and access to care in a digital platform for employers and members. | €480M | Series GSeries C+ | Healthtech, Fintech | France | Investors | |
| LL Leyden LaboratoriesCompany profile Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections. Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections. | €40M | Series B | Healthtech, Biotech | Netherlands | Investors | |
| T TissiumCompany profile Develops biomorphic programmable polymers that repair nerves and tissue without stitches Develops biomorphic programmable polymers that repair nerves and tissue without stitches | €30M | Series D+Series C+ | Healthtech | France | Investors | |
| x Transforms fragmented medical records into decision-ready data | $46M | Series B | Healthtech | United States | Investors | |
| AH Assort HealthCompany profile Provides AI-powered patient journey platform for healthcare organizations Provides AI-powered patient journey platform for healthcare organizations | $120M | Series CSeries C+ | Healthtech | United States | Investors | |
| OB Ollin BiosciencesCompany profile Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD | $330M | Series B | Healthtech, Biotech | United States | Investors | |
| AN Anodyne NanotechCompany profile Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections | $12.6M | Series A | Healthtech, Biotech | United States | Investors | |
| RB RQ BioCompany profile Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients | $115M | Series A | Healthtech, Biotech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.